The Small and Medium Pharmaceutical Industry Centre (SMPIC), NIPER-SAS, Chandigarh will be organizing a one-day seminar on ‘Risk Analysis’ on August 26, 2011.

Prof. K K Bhutani, director, NIPER informed that the preparations for the seminar are underway and good response is being received from SME pharma companies, consultants and academia to attend this one day event.

Dr. Sanjay Jachak, associate professor and in-charge, SMPIC further informed that the presentations in this seminar will be delivered by the eminent speakers from Regulatory bodies and Pharma industries such Dr D Roy, DDC, CDSCO-North Zone, Ghaziabad; Kapil Bhargava, Ex-DDC, CDSCO, Kolkata; Dr J P Khurana, Ranbaxy Laboratories Ltd., Mohali and Pravin Manker, P P M Consultants, Mumbai. About 100 delegates from SME Pharma companies are expected to attend the seminar.

SMPIC since its inception in 2009 has been continuously organizing the seminars on the current topics relevant to SME pharma companies. In continuation of the series of seminars to bring awareness to pharma professionals, now SMPIC is announcing to organize the seminar on ‘Risk Analysis.'

Every pharma enterprise should have a methodology for identifying and evaluating the risks it faces and it should have a process for generating intervention plans to reduce the risks to an acceptable level. This process is generally referred to as a Risk Management Plan. A Risk Management Program starts with identifying the possible risks (and benefits) associated with a product or with the process used to develop, manufacture, and distribute the product. Thus, the risk analysis of a pharmaceutical product includes its manufacturing processes, analytical procedures, various supporting facilities required at various stages of product manufacture, and supply, distribution channel of the product.